Latest stories on GRI
GRI Bio announces new translational biomarker data from GRI-0621-IPF-02 study
The Fly59 · neutralproduct/pr
GRI Bio Reports Positive Phase 2a IPF Biomarker Data
TipRanks67 · bullishproduct/pr
GRI Bio, Inc. (GRI) files 8-K
SEC 8-K50 · neutralgeneral
GRI Bio Presents New Phase 2a Data at ERS 2026 Defining GRI-0621's Mechanism of Action in IPF Across Nine Mechanistic Pillars
Business Insider63 · neutralproduct/pr
GRI Bio Featured in "Why Now" On-Demand Video Webcast
StockTitan56 · neutralproduct/pr
GRI Bio Secures FDA Orphan Drug Status for IPF
TipRanks73 · bullishproduct/pr
GRI Bio, Inc. (GRI) files 8-K
SEC 8-K50 · neutralgeneral
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis | GRI Stock News
StockTitan67 · bullishproduct/pr